|
ABOUT COMPANY
X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for the treatment of back diseases. The company is headquartered in Boston, Massachusetts.
|
EARNINGS
Gross Profit (TTM): 3000000
Market Capitalization: 64412000
Operating Margin (TTM): 0
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0
Revenue (TTM): 0
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -3.615
Dividend Date: 2019-03-14
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -40355000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|